- Home
- LUNG vs OSUR Comparison
LUNG vs OSUR Comparison
Compare LUNG & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- OSUR
- Stock Information
- Founded
- LUNG 1995
- OSUR 2000
- Country
- LUNG United States
- OSUR United States
- Employees
- LUNG N/A
- OSUR N/A
- Industry
- LUNG Industrial Specialties
- OSUR Medical/Dental Instruments
- Sector
- LUNG Health Care
- OSUR Health Care
- Exchange
- LUNG Nasdaq
- OSUR Nasdaq
- Market Cap
- LUNG N/A
- OSUR 223.0M
- IPO Year
- LUNG 2020
- OSUR 1986
- Fundamental
- Price
- LUNG $3.64
- OSUR $2.60
- Analyst Decision
- LUNG Strong Buy
- OSUR Hold
- Analyst Count
- LUNG 7
- OSUR 2
- Target Price
- LUNG $12.07
- OSUR $5.50
- AVG Volume (30 Days)
- LUNG 416.9K
- OSUR 444.5K
- Earning Date
- LUNG 04-30-2025
- OSUR 05-07-2025
- Dividend Yield
- LUNG N/A
- OSUR N/A
- EPS Growth
- LUNG N/A
- OSUR N/A
- EPS
- LUNG N/A
- OSUR N/A
- Revenue
- LUNG $87,473,000.00
- OSUR $161,626,000.00
- Revenue This Year
- LUNG $17.97
- OSUR N/A
- Revenue Next Year
- LUNG $18.88
- OSUR $7.55
- P/E Ratio
- LUNG N/A
- OSUR N/A
- Revenue Growth
- LUNG 19.84
- OSUR N/A
- 52 Week Low
- LUNG $4.15
- OSUR $2.69
- 52 Week High
- LUNG $10.01
- OSUR $5.59
- Technical
- Relative Strength Index (RSI)
- LUNG 26.86
- OSUR 30.12
- Support Level
- LUNG $3.39
- OSUR $2.91
- Resistance Level
- LUNG $5.46
- OSUR $3.09
- Average True Range (ATR)
- LUNG 0.43
- OSUR 0.11
- MACD
- LUNG -0.06
- OSUR -0.02
- Stochastic Oscillator
- LUNG 12.92
- OSUR 26.47
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.